NASDAQ · GSIT

GSI Technology

$5.79 +$0.16 (+2.84%) 1D Pre-market
Charting by TradingView

Key Metrics

$216.03M
Market cap
—
P/E · TTM
$25.12M
Revenue · TTM
−$13.25M
Net income
EPS · TTM $-0.53
Dividend yield —
Free cash flow −$16.41M
Beta · 1Y 3.85
EBITDA · TTM −$12.75M
Gross margin 54.5%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    From its May 13 high, the share price fell 56%.

    Peak close $12.26 on May 13; trough close $5.39 on Jul 16. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -56%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 11
    The stock moved +38.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 11
  • Mar 18
    The stock moved -30.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 18

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$216.03M
Enterprise value—
Shares outstanding38.4M
52-wk range$2.82 – $18.15
Avg volume · 20D792.8K
Net cash —
Book value / share$3.25
IndustrySemiconductors & Related Devices
ExchangeNASDAQ
About GSI Technology
IPO dateMar 29, 2007
Employees125

GSI Technology Inc is a provider of semiconductor memory solutions.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S8.60
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—

Profitability

Gross 54.5%
Operating -53.3%
Net -52.7%
FCF -65.3%
ROE / ROIC -24.1% · -91.0%

Financial Health

Current ratio8.61
Quick ratio8.17
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$69.99M

Cash Flow · TTM

Operating CF −$15.92M
Capex −$486.00K
Free cash flow −$16.41M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

8.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings